Projects funded by the NCN

EMMPRIN role in rat model of subarachnoid hemorrhage and in minocycline neuroprotective mechanisms.

Call: PRELUDIUM 6 , Panel: NZ7

Principal investigator: Daria Irena Gendosz

Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m...

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende...

Call: SONATA 20 , Panel: NZ7

Principal investigator: dr Hanna Kletkiewicz

Uniwersytet Mikołaja Kopernika w Toruniu

Effect of Urolithin A on gut microbiota and intestinal integrity contributing to neuroprotective effects in a model of P...

Call: PRELUDIUM 23 , Panel: NZ7

Principal investigator: Olga Wojciechowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

Call: OPUS 26 , Panel: NZ7

Principal investigator: prof. Jadwiga Handzlik

Uniwersytet Jagielloński, Collegium Medicum

The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain...

Call: SONATA BIS 13 , Panel: NZ7

Principal investigator: dr Bartosz Sebastian Pomierny

Uniwersytet Jagielloński, Collegium Medicum

Neuroprotective effect of SGLT2i: direct influence on amyloid-β related pathology

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Agnieszka Pawlos

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

Call: PRELUDIUM 22 , Panel: NZ7

Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Neuroprotective properties of β-cyclodextrin-1,2,4-triazole inclusion complexes

Call: PRELUDIUM BIS 4 , Panel: NZ7

Principal investigator: prof. Tomasz Sylwester Plech

Uniwersytet Medyczny w Lublinie

The role of GPR39 receptor in the mechanism of antidepressant action

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Katarzyna Młyniec

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

Call: OPUS 23 , Panel: NZ7

Principal investigator: prof. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński, Collegium Medicum

Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Karolina Barbara Przepiórska-Drońska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of ...

Call: SONATA 17 , Panel: NZ7

Principal investigator: dr Agnieszka Wnuk

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Multifunctional plant systems as a complex way of providing neuroprotective activity

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: dr Anna Stasiłowicz-Krzemień

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Selective activation of non-nuclear Estrogen Receptor signaling with PaPE-1 as a novel therapeutic approach for sporadic...

Call: OPUS 20 , Panel: NZ7

Principal investigator: prof. Małgorzata Kajta

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain ...

Call: OPUS 20 , Panel: NZ7

Principal investigator: prof. Piotr Warszyński

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera Polskiej Akademii Nauk

Strategies to protect against methamphetamine-induced neurotoxicity

Call: OPUS 18 , Panel: NZ7

Principal investigator: prof. Michał Jan Toborek

Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach, Instytut Fizjoterapii i Nauk o Zdrowiu

Evaluation of molecular mechanisms of neuroprotective action of dental pulp stromal cells in an ex vivo organotypic mode...

Call: PRELUDIUM 18 , Panel: NZ7

Principal investigator: dr Natalia Helena Bryniarska-Kubiak

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng...

Call: PRELUDIUM 18 , Panel: NZ7

Principal investigator: Justyna Beata Barut

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Theranostic nanocarriers for drug delivery in central nervous system disorders

Call: GRIEG 1 , Panel: ST5

Principal investigator: prof. Piotr Warszyński

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera Polskiej Akademii Nauk

Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur...

Call: PRELUDIUM 17 , Panel: NZ7

Principal investigator: Marcin Józef Drop

Uniwersytet Jagielloński, Collegium Medicum

Searching for effective strategies to protect neuronal cells against hypoxia and ischemia: Identification of neuroprotec...

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Małgorzata Kajta

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

How microglia-astrocyte interaction affects neuronal functioning in the dopaminergic system. Analysis of the protective ...

Call: OPUS 14 , Panel: NZ7

Principal investigator: dr Katarzyna Zofia Kuter

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Expression of microRNA and its effect on the level of proteins with neuroprotective properties in the pathogenesis of th...

Call: OPUS 14 , Panel: NZ7

Principal investigator: prof. Ireneusz Jacek Majsterek

Uniwersytet Medyczny w Łodzi, Wydział Lekarski; Oddział Lekarski

Urolithin A as a metabolite of ellagitannins with potential neuroprotective activity - the research of mechanisms of thi...

Call: SONATA 13 , Panel: NZ7

Principal investigator: dr Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Glaucoma neuroprotection with BDNF on the level of retinal and primary visual cortex

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Anna Wójcik- Gryciuk

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

Investigation of the mechanisms of the neuroprotective effect of group II metabotropic receptors (mGluR2/3) agonist in a...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: dr Ewelina Małgorzata Bratek

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

The influence of body temperature during perinatal hypoxia on the level of neurotrophic-derived factor (BDNF) - new appr...

Call: PRELUDIUM 11 , Panel: NZ7

Principal investigator: Hanna Kletkiewicz

Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Biologii i Ochrony Środowiska

Normal021falsefalsefalseMicrosoftInternetExplorer4/* Style Definitions */table.MsoNormalTable{mso-style-name:Standardowy...

Call: SONATA 1 , Panel: NZ7

Principal investigator: dr Anna Gąsiorowska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

The influence of a new hybryd compound derived from 2-(2,5-dioxopyrrolidin-1-yl) propanamide on hippocampal neuroprotect...

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Marta Andres-Mach

Instytut Medycyny Wsi im. Witolda Chodźki

Neuroprotective role of the GPR39 receptor in the central nervous system. Its relationship to Alzheimer Disease.

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Młyniec

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny